Global At-Home Health Testing Platform Market Growth (Status and Outlook) 2023-2029

Global At-Home Health Testing Platform Market Growth (Status and Outlook) 2023-2029

Home use tests allow you to test for some diseases or conditions at home. These tests are cost-effective, quick, and confidential. The At-Home Health Testing Platform market covers Men’s Tests, Women’s Tests, Infectious Disease Testing, Wellness, etc. The typical players include Everlywell, Modern Fertility, Future Family, 23andMe, Cue Health, LetsGetChecked, ixlayer, AIDE Mobile App, etc.
LPI (LP Information)' newest research report, the “At-Home Health Testing Platform Industry Forecast” looks at past sales and reviews total world At-Home Health Testing Platform sales in 2022, providing a comprehensive analysis by region and market sector of projected At-Home Health Testing Platform sales for 2023 through 2029. With At-Home Health Testing Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world At-Home Health Testing Platform industry.
This Insight Report provides a comprehensive analysis of the global At-Home Health Testing Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on At-Home Health Testing Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global At-Home Health Testing Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for At-Home Health Testing Platform and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global At-Home Health Testing Platform.
The global At-Home Health Testing Platform market size is projected to grow from US$ 3234.3 million in 2022 to US$ 11420 million in 2029; it is expected to grow at a CAGR of 19.8% from 2023 to 2029.
Global key players of at-home health testing platform include 23andMe, Everlywell, LetsGetChecked, Pixel by LabCorp, Modern Fertility, etc. The top five players hold a share about 17%. Service providers are mainly located in Europe, North America and China, they occupied for a share over 20%. The largest market is North America, holds a share about 54%, followed by Europe and China, with around 27% and 6% market share respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of At-Home Health Testing Platform market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
General Health
Men's Health
Women's Health
Infectious Disease Detection
Segmentation by application
Consumer-Grade Diagnostics
Clinical Grade Diagnosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
New Horizon Health Limited
Test Onelife
Creative Biosciences (Guangzhou)
AnDall
Everlywell
Modern Fertility
23andMe
Cue Health
LetsGetChecked
ixlayer
Pixel by LabCorp

Please note: The report will take approximately 2 business days to prepare and deliver.